Business Wire

YOKOGAWA-ELECTRIC

15.2.2024 03:01:28 CET | Business Wire | Press release

Share
Yokogawa Provides Remote Operation/Monitoring System and Video Monitoring Solution for Japan’s Largest Wind Farm

Yokogawa Electric Corporation (TOKYO: 6841) announces that its subsidiary Yokogawa Solution Service Corporation has completed the design, supply, and commissioning of a remote operation and monitoring system based on the OpreX™ Collaborative Information Server for the offshore wind turbines and onshore facilities at the Ishikari Bay New Port Offshore Wind Farm. The company has also contracted to provide maintenance services at this wind farm, which is operated by JERA Co., Inc. and the Green Power Investment Corporation and owned through Green Power Ishikari GK, a special-purpose corporation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240213110562/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Ishikari Bay New Port Offshore Wind Farm (Source: Green Power Investment Corporation)

The Ishikari Bay New Port Offshore Wind Farm is the first wind farm in Japan to use large-scale 8,000kW wind turbines, and as of the start of commercial operations on January 1, 2024, it is the largest commercial wind farm in Japan. The remote operation and monitoring system supplied by Yokogawa includes a video system for the monitoring of all the offshore and onshore wind power generating facilities at this wind farm. On an ongoing basis, the company will also provide maintenance services for these systems.

At the core of this remote operation and monitoring system is Yokogawa’s Collaborative Information Server, a solution that offers centralized management of data from the offshore wind turbines, the transformer substation’s large-scale storage batteries, and cameras installed on the wind turbines and storage batteries, and in the turbine maintenance yard. This video monitoring system utilizes the Edge Gateway AG 10 (for indoor) solution provided by Yokogawa subsidiary amnimo Inc.

Wind is a renewable energy source, and the amount of electricity produced varies depending on weather conditions. Taking into account information on power demand provided by the transmission system operator, this remote operation and monitoring system provides the data required to control the amount of power that will be stored by the storage battery system.

In addition to the systems delivered for this project, Yokogawa Solution Service has also received orders from Green Power Investment Corporation for systems that will aggregate information in real-time from wind farms all around Japan, and link this with cloud-based analysis tools. And together with Green Power Investment, Yokogawa Solution Service has commenced proof-of-concept tests in which the DTSX3000 optical fiber temperature sensor, a product in the OpreX Field Instruments lineup, is utilized to detect signs of damage to the submarine cables at the Ishikari Bay New Port Offshore Wind Farm.

Yokogawa is firmly focused on developing the system of systems (SoS) concept, whereby systems work together as a whole while maintaining operational and management independence to achieve, in an emergent way, goals that cannot be achieved independently. While there are many types of equipment and system configurations at wind farms, Yokogawa possesses the operational technology (OT) know-how needed to interpret data from sensors and other devices and thereby identify how the equipment and systems should be linked to achieve optimization at the individual and collective levels. By leveraging this know-how to provide solutions that cover everything from operation to overall system maintenance, Yokogawa will contribute to the realization of a decarbonized society.

About Yokogawa

Yokogawa provides advanced solutions in the areas of measurement, control, and information to customers across a broad range of industries, including energy, chemicals, materials, pharmaceuticals, and food. Yokogawa addresses customer issues regarding the optimization of production, assets, and the supply chain with the effective application of digital technologies, enabling the transition to autonomous operations.
Founded in Tokyo in 1915, Yokogawa continues to work toward a sustainable society through its 17,000+ employees in a global network of 129 companies spanning 60 countries.
For more information, visit www.yokogawa.com

The names of corporations, organizations, products, services and logos herein are either registered trademarks or trademarks of Yokogawa Electric Corporation, or their respective holders.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240213110562/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye